Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206


Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.

Chahlavi A, Rayman P, Richmond AL, Biswas K, Zhang R, Vogelbaum M, Tannenbaum C, Barnett G, Finke JH.

Cancer Res. 2005 Jun 15;65(12):5428-38.


Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.

Wischhusen J, Jung G, Radovanovic I, Beier C, Steinbach JP, Rimner A, Huang H, Schulz JB, Ohgaki H, Aguzzi A, Rammensee HG, Weller M.

Cancer Res. 2002 May 1;62(9):2592-9.


Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathways.

Das T, Sa G, Paszkiewicz-Kozik E, Hilston C, Molto L, Rayman P, Kudo D, Biswas K, Bukowski RM, Finke JH, Tannenbaum CS.

J Immunol. 2008 Apr 1;180(7):4687-96.


The role of apoptosis in normal ontogenesis and solid human neoplasms.

Kaiser HE, Bodey B.

In Vivo. 2000 Nov-Dec;14(6):789-803.


GM1 and tumor necrosis factor-alpha, overexpressed in renal cell carcinoma, synergize to induce T-cell apoptosis.

Das T, Sa G, Hilston C, Kudo D, Rayman P, Biswas K, Molto L, Bukowski R, Rini B, Finke JH, Tannenbaum C.

Cancer Res. 2008 Mar 15;68(6):2014-23. doi: 10.1158/0008-5472.CAN-07-6037.


Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.

Avril T, Saikali S, Vauleon E, Jary A, Hamlat A, De Tayrac M, Mosser J, Quillien V.

J Neuroimmunol. 2010 Aug 25;225(1-2):22-33. doi: 10.1016/j.jneuroim.2010.04.003. Epub 2010 May 20.


Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells.

Kudo D, Rayman P, Horton C, Cathcart MK, Bukowski RM, Thornton M, Tannenbaum C, Finke JH.

Cancer Res. 2003 Apr 1;63(7):1676-83.


Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.

Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL.

J Immunol. 1999 Nov 15;163(10):5358-66.


Topotecan enhances immune clearance of gliomas.

Wei J, DeAngulo G, Sun W, Hussain SF, Vasquez H, Jordan J, Weinberg J, Wolff J, Koshkina N, Heimberger AB.

Cancer Immunol Immunother. 2009 Feb;58(2):259-70. doi: 10.1007/s00262-008-0550-1. Epub 2008 Jul 2.


Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation.

Hintzen RQ, Lens SM, Lammers K, Kuiper H, Beckmann MP, van Lier RA.

J Immunol. 1995 Mar 15;154(6):2612-23.


FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.

Lawrence CP, Chow SC.

FEBS Lett. 2005 Nov 21;579(28):6465-72. Epub 2005 Nov 2.


Characterization of murine CD70 by molecular cloning and mAb.

Oshima H, Nakano H, Nohara C, Kobata T, Nakajima A, Jenkins NA, Gilbert DJ, Copeland NG, Muto T, Yagita H, Okumura K.

Int Immunol. 1998 Apr;10(4):517-26.


Signalling via CD70, a member of the TNF family, regulates T cell functions.

García P, De Heredia AB, Bellón T, Carpio E, Llano M, Caparrós E, Aparicio P, López-Botet M.

J Leukoc Biol. 2004 Jul;76(1):263-70.


Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors.

Schimmer AD, Thomas MP, Hurren R, Gronda M, Pellecchia M, Pond GR, Konopleva M, Gurfinkel D, Mawji IA, Brown E, Reed JC.

Cancer Res. 2006 Feb 15;66(4):2367-75.


Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.

Prado-Garcia H, Aguilar-Cazares D, Meneses-Flores M, Morales-Fuentes J, Lopez-Gonzalez JS.

Cancer Immunol Immunother. 2008 Mar;57(3):325-36. Epub 2007 Aug 1.


Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells.

Lens SM, Baars PA, Hooibrink B, van Oers MH, van Lier RA.

Immunology. 1997 Jan;90(1):38-45.


CD27-CD70 interactions regulate B-cell activation by T cells.

Kobata T, Jacquot S, Kozlowski S, Agematsu K, Schlossman SF, Morimoto C.

Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11249-53.

Supplemental Content

Support Center